UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 66

Sortiert nach

The impact of smoking cessation on multiple sclerosis disease progression

Brain (London, England : 1878), 2022-05, Vol.145 (4), p.1368-1378

2022

Volltextzugriff (PDF)

A Review of Compartmentalised Inflammation and Tertiary Lymphoid Structures in the Pathophysiology of Multiple Sclerosis

Biomedicines, 2022-10, Vol.10 (10), p.2604

2022

Volltextzugriff (PDF)

Comorbidities in MS are associated with treatment intolerance and disability

Neurology, 2017-11, Vol.89 (22), p.2218

2017

Volltextzugriff (PDF)

Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary

Neurology, 2016-04, Vol.86 (14), p.1361

2016

Volltextzugriff (PDF)

Real‐world persistence of multiple sclerosis disease‐modifying therapies

European journal of neurology, 2024-07, Vol.31 (7), p.e16289-n/a

2024

Volltextzugriff (PDF)

CCN3 is dynamically regulated by treatment and disease state in multiple sclerosis

Journal of neuroinflammation, 2020-11, Vol.17 (1), p.349-349, Article 349

2020

Volltextzugriff (PDF)

Reduced Cone Density Is Associated with Multiple Sclerosis

Ophthalmology science (Online), 2023-09, Vol.3 (3), p.100308-100308, Article 100308

2023

Volltextzugriff (PDF)

Patient-reported outcomes in multiple sclerosis: a prospective registry cohort study

Brain communications, 2023-07, Vol.5 (4), p.fcad199-fcad199

2023

Volltextzugriff (PDF)

Meningeal inflammation and cortical demyelination in acute multiple sclerosis

Annals of neurology, 2018-12, Vol.84 (6), p.829-842

2018

Volltextzugriff (PDF)

Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years

Neurology, 2021-02, Vol.96 (5), p.e783

2021

Volltextzugriff (PDF)

CAN A RAPID ACCESS NEUROLOGY CLINIC REDUCE A&E ADMISSIONS?

Journal of neurology, neurosurgery and psychiatry, 2014-10, Vol.85 (10), p.e4.159-e4

2014

Volltextzugriff (PDF)

Bi-allelic JAM2 Variants Lead to Early-Onset Recessive Primary Familial Brain Calcification

American journal of human genetics, 2020-03, Vol.106 (3), p.412-421

2020

Volltextzugriff (PDF)

Teaching NeuroImages: facial diplegia due to neuroborreliosis

Neurology, 2014-01, Vol.82 (2), p.e16

2014

Volltextzugriff (PDF)

Factors influencing multiple sclerosis disease-modifying treatment prescribing decisions in the United Kingdom: A qualitative interview study

Multiple sclerosis and related disorders, 2019-01, Vol.27, p.378-382

2019

Volltextzugriff (PDF)

Cardiovascular risk factors in secondary progressive multiple sclerosis: A cross‐sectional analysis from the MS‐STAT2 randomized controlled trial

European journal of neurology, 2023-09, Vol.30 (9), p.2769-2780

2023

Volltextzugriff (PDF)

A Rapid Electronic Cognitive Assessment Measure for Multiple Sclerosis: Validation of Cognitive Reaction, an Electronic Version of the Symbol Digit Modalities Test

Journal of medical Internet research, 2020-09, Vol.22 (9), p.e18234-e18234

2020

Volltextzugriff (PDF)

A bad dose of 'flu

Postgraduate medical journal, 2002-06, Vol.78 (920), p.373-373

McDonnell, G V

2002

Volltextzugriff (PDF)

Developing an Interoperable Port Health Contingency Plan

Medical sciences forum, 2022-12, Vol.13 (1), p.20

2022

Volltextzugriff (PDF)

CAN A RAPID ACCESS NEUROLOGY CLINIC REDUCE A&E ADMISSIONS?

Emergency medicine journal : EMJ, 2014-09, Vol.31 (9), p.779-780

2014

Volltextzugriff (PDF)

Intravenous immunoglobulins for multiple sclerosis

Cochrane database of systematic reviews, 2003-07 (4), p.CD002936

2003

Volltextzugriff (PDF)

Acute neuromuscular respiratory failure: a population-based study of aetiology and outcome in Northern Ireland

Postgraduate medical journal, 2014-04, Vol.90 (1062), p.201-204

2014

Volltextzugriff (PDF)

The contemporary role of MRI in the monitoring and management of people with multiple sclerosis in the UK

Multiple sclerosis and related disorders, 2021-10, Vol.55, p.103190-103190, Article 103190

2021

Volltextzugriff (PDF)

Re: Tumefactive multiple sclerosis lesions under fingolimod treatment

Neurology, 2013-07, Vol.81 (4), p.403

2013

Volltextzugriff (PDF)

Pharmacogenomics of responsiveness to interferon IFN-β treatment in multiple sclerosis: A genetic screen of 100 type I interferon-inducible genes

Clinical pharmacology and therapeutics, 2005-12, Vol.78 (6), p.635-646

2005

Volltextzugriff (PDF)

Helping patients and the emergency department: enhanced patient care and reduced hospital admission rates with a pilot rapid access neurology clinic (RANC)

Clinical medicine (London, England), 2015-06, Vol.15 (3), p.s10-s10

2015

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(53)

Publikationsform

Sprache

Englisch
(66)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(40)
Life Sciences & Biomedicine
(39)
Humans
(37)
Neurosciences & Neurology
(19)
Multiple Sclerosis
(17)
Clinical Neurology
(15)
Female
(15)
Male
(15)
Adult
(14)
General & Internal Medicine
(11)
Middle Aged
(11)
Neurosciences
(11)
Medicine, General & Internal
(9)
Neurology
(9)
Multiple Sclerosis - Genetics
(7)
Disease Progression
(6)
Patients
(6)
Aged
(5)
Disability Evaluation
(5)
Emergency Medical Services - Methods
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Resuscitation
(6)
Neurology
(5)
Bmj Open
(4)
Age And Ageing
(3)
Journal Of Neuroimmunology
(3)
Postgraduate Medical Journal
(3)
Annals Of Neurology
(2)
Cancer Research
(2)
Cochrane Database Of Systematic Reviews
(2)
Cochrane Library
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The impact of smoking cessation on multiple sclerosis disease progression

A Review of Compartmentalised Inflammation and Tertiary Lymphoid Structures in the Pathophysiology of Multiple Sclerosis

Comorbidities in MS are associated with treatment intolerance and disability

Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary

Real‐world persistence of multiple sclerosis disease‐modifying therapies

CCN3 is dynamically regulated by treatment and disease state in multiple sclerosis

Reduced Cone Density Is Associated with Multiple Sclerosis

Patient-reported outcomes in multiple sclerosis: a prospective registry cohort study

Meningeal inflammation and cortical demyelination in acute multiple sclerosis

Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years

CAN A RAPID ACCESS NEUROLOGY CLINIC REDUCE A&E ADMISSIONS?

Bi-allelic JAM2 Variants Lead to Early-Onset Recessive Primary Familial Brain Calcification

Teaching NeuroImages: facial diplegia due to neuroborreliosis

Factors influencing multiple sclerosis disease-modifying treatment prescribing decisions in the United Kingdom: A qualitative interview study

Cardiovascular risk factors in secondary progressive multiple sclerosis: A cross‐sectional analysis from the MS‐STAT2 randomized controlled trial

A Rapid Electronic Cognitive Assessment Measure for Multiple Sclerosis: Validation of Cognitive Reaction, an Electronic Version of the Symbol Digit Modalities Test

A bad dose of 'flu

Developing an Interoperable Port Health Contingency Plan

CAN A RAPID ACCESS NEUROLOGY CLINIC REDUCE A&E ADMISSIONS?

Intravenous immunoglobulins for multiple sclerosis

Acute neuromuscular respiratory failure: a population-based study of aetiology and outcome in Northern Ireland

The contemporary role of MRI in the monitoring and management of people with multiple sclerosis in the UK

Re: Tumefactive multiple sclerosis lesions under fingolimod treatment

Pharmacogenomics of responsiveness to interferon IFN-β treatment in multiple sclerosis: A genetic screen of 100 type I interferon-inducible genes

Helping patients and the emergency department: enhanced patient care and reduced hospital admission rates with a pilot rapid access neurology clinic (RANC)

Suchergebnisse filtern